Innovation Partner:
NanoFCM designs advanced analytical instrumentation allowing the measurement of biological and synthetic substrates, such as lipid nanoparticles, extracellular vesicles and viruses. The NanoAnalyzer platform offers a flexible, high throughput solution to for the single-particle, multiparameter characterization of novel nano-sized therapeutics using nano-flow cytometry. By measuring simultaneously physical size, concentration and therapeutic content, the NanoAnalyzer can assess the encapsulation rate of API in individual nanoparticles, speeding up development, approval and quality control of novel drugs and vaccines.
Innovation Partner:
Spectradyne has provided cutting-edge analytical instrumentation for the nanomedicine community since 2013. Its ARC particle analyzer uniquely combines two orthogonal analysis techniques in a fast and easy-to-use instrument to measure LNP size, concentration, targeting ligands, and payload on a single-particle basis. The ARC requires no alignment, calibration or cleaning, and delivers fast, accurate results that match Cryo TEM.
Exhibition Partner:
SCIEX delivers solutions for the precision detection and quantification of molecules, empowering our customers to protect and advance the wellness and safety of all. Today, as part of the Danaher family of global life science and technology innovators, we continue to pioneer robust solutions in mass spectrometry and capillary electrophoresis. SCIEX helps scientists in biopharma discovery, development and manufacturing to transform pipeline capacity and capability through the adoption of CE and LC-MS technologies. You benefit from innovative technology that makes complex workflows easier and more efficient, while delivering the utmost in data quality. Highly reliable instrumentation, with high sensitivity and dynamic range for a variety of analytical applications. Advanced software with automation to make data processing easier. That’s why thousands of life science experts around the world choose SCIEX to get the answers they can trust to better inform critical decisions that positively impact lives.
Exhibition Partner:
Headquartered in Oss, the Netherlands, InProcess-LSP is a pioneer in Process Analytical Technology (PAT) solutions. Since its founding in 2014, the company has grown rapidly, driven by its groundbreaking innovation—the NanoFlowSizer.
With extensive expertise in PAT and nanoparticle characterization, InProcess-LSP addresses the industry’s increasing need for complete quality control in pharmaceutical production. The company supports leading pharmaceutical manufacturers, including producers of COVID-19 vaccines, in developing and monitoring complex medicines and vaccines. Many of these products contain nanoparticles, where particle size plays a critical role in ensuring safety, stability, and efficacy.
As the inventors of the NanoFlowSizer, InProcess-LSP introduced the first and only instrument capable of real-time, non-invasive nanoparticle size measurement in flow—even in highly turbid suspensions. This unique technology enables continuous, in-process analysis within seconds, eliminating the need for time-consuming sample preparation.
By providing companies with real-time insights into nanoparticle size and distribution, InProcess-LSP helps ensure robust manufacturing processes and high-quality pharmaceutical products.
Event Partner:
For over 30 years, we have helped the world’s most innovative bio/biopharmaceutical companies navigate the challenges of new product development, drug delivery, production, and market release. We provide a broad range of cGMP, GLP, GCP laboratory services, with a focus on support for the development and production of mRNA, oligos, peptides, biologics, or vaccines. We are adept in establishing GMP validated analytical methods, including mRNA specific methods such as integrity, potency, capping efficiency, sequencing, Poly(A) Tail, residual DNA template, residual dsRNA and delivery system testing (e.g. lipid nanoparticles (LNPs)). These comprehensive characterisation services provide data to determine protein expression and product purity, which can be directly linked to translation efficiency and immunogenicity. We also provide ICH stability and formulation development programs and have leading expertise in the product development of inhaled and nasal drugs. Our outsourcing contracts are flexible and can be tailored to your specific timelines, requirements, and budgets.